Last updated at 29 Jun 2024 02:22 AM
Director
DIN: 01922109
Baiju Bhupendrabhai Desai is currently associated with 1 company in various capacities such as Individual Promoter and Director. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01922109.Baiju Bhupendrabhai Desai has previously been associated with 4 companies in roles such as Director and Designated Partner.Baiju Bhupendrabhai Desai is currently involved in 2 different roles. Their most recent position is with CLAROID PHARMACEUTICALS PRIVATE LIMITED as a Individual Promoter. The first company Baiju Bhupendrabhai Desai was appointed to as a director was CLAROID PHARMACEUTICALS PRIVATE LIMITED. Baiju Bhupendrabhai Desai is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Baiju Bhupendrabhai Desai is currently associated with 1 company in various capacities such as Individual Promoter and Director. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01922109.Baiju Bhupendrabhai Desai has previously been associated with 4 companies in roles such as Director and Designated Partner.Baiju Bhupendrabhai Desai is currently involved in 2 different roles. Their most recent position is with CLAROID PHARMACEUTICALS PRIVATE LIMITED as a Individual Promoter. The first company Baiju Bhupendrabhai Desai was appointed to as a director was CLAROID PHARMACEUTICALS PRIVATE LIMITED. Baiju Bhupendrabhai Desai is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (0)
Past Companies (4)
5y 10m 2y 11m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| CLAROID PHARMACEUTICALS PRIVATE LIMITED | Individual Promoter | 31-Aug-2018 |
| CLAROID PHARMACEUTICALS PRIVATE LIMITED | Director | 31-Aug-2018 |